Related Experiment Video
Updated: Jul 15, 2026
11:32
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Pneumococcal vaccines for children and adults with bronchiectasis
C C Chang1, R J Singleton, P S Morris
1Geelong Hospital, Infectious Diseases, 109 Station Street, Carlton, Victoria, Australia, 3053. ccchang339@hotmail.com
The Cochrane Database of Systematic Reviews
|April 20, 2007
Summary
Pneumococcal vaccines are not proven to help children or adults with bronchiectasis. More research is needed to determine if these vaccines reduce exacerbations or slow lung decline in bronchiectasis patients.
Area of Science:
- Pulmonology
- Immunology
- Clinical Trials
Background:
- Bronchiectasis is a significant cause of respiratory illness globally, particularly in developing nations and specific communities like Aboriginal populations.
- Respiratory exacerbations in bronchiectasis patients lead to reduced quality of life, accelerated lung function decline, hospitalizations, and mortality.
- Pneumococcal conjugate vaccines are standard in infant immunizations, with current guidelines recommending them for individuals with chronic suppurative lung diseases.
Purpose of the Study:
- To assess the effectiveness of pneumococcal vaccination in managing bronchiectasis in children and adults.
- To determine if vaccination reduces the severity and frequency of respiratory exacerbations.
- To evaluate the impact of vaccination on pulmonary decline in bronchiectasis patients.
Main Methods:
- Searched major databases (CENTRAL, Cochrane Airways Group Register, MEDLINE, EMBASE) and contacted vaccine manufacturers.
- Included all randomized controlled trials (RCTs) of pneumococcal vaccines in children and adults with bronchiectasis.
- Searches were last conducted in October 2006.
Main Results:
- No RCTs were identified to evaluate the effectiveness of pneumococcal vaccines in bronchiectasis.
- One small non-randomized trial in children suggested a potential benefit in eliminating Streptococcus pneumoniae from sputum, but no clinical effects were reported.
- Insufficient data exists to confirm efficacy or safety.
Conclusions:
- There is a lack of reliable evidence to support or oppose the routine use of pneumococcal vaccines for bronchiectasis management.
- Further RCTs are required to investigate the efficacy of different pneumococcal vaccine types across various age groups with bronchiectasis.
- Healthcare providers should follow existing national guidelines for pneumococcal vaccination in bronchiectasis patients pending further evidence.
More Related Videos
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...